Literature DB >> 728103

Phospholipid composition and metabolism in mouse muscular dystrophy.

C T Kwok, L Austin.   

Abstract

1. The composition and metabolism of phospholipids were studied in various tissues from both normal and dystrophic mice of the 129 ReJ strain. Phospholipids extracted from forebrain, spinal cord, sciatic nerve and plasma were fractionated by t.l.c. and measured. 2. Very significant alterations were found in the choline phospholipids from these tissues, except forebrain. Plasma phosphatidylcholine in the dystrophic mouse was increased by 38%. There was a 2-fold increase in lysophosphatidylcholine in the spinal cord of dystrophic mice. The sciatic nerve showed a marked decrease in sphingomyelin content, which is approximately half of that in the controls. 3. Five enzymes involved in phosphatidylcholine metabolism [namely cholinephosphotransferase (EC 2.7.8.2); phospholipases A (EC 3.1.1.4, EC 3.1.1.32); lysophospholipase (EC 3.1.1.5); lysophosphatidylcholine acyltransferase (EC 2.3.1.23); phospholipase C (EC 3.1.4.3)] were studied in tissue preparations from forebrain, spinal cord, sciatic nerves, gastrocnemius muscles and liver. 4. Activities of phospholipases A and C were significantly increased, about 5-fold and 60% respectively, in gastrocnemius muscle of dystrophic mice compared with controls. Phospholipases A also showed 50% higher activity in the sciatic nerves of dystrophic than of normal mice. Lysophosphatidylcholine acyltransferase activities were significantly increased in the sciatic nerves and spinal cord, by 50-100% over that of the controls. The forebrain and spinal cord from dystrophic mice, however, had only 60% of lysophospholipase activities of that of the normal control. Cholinephosphotransferase activity was unchanged in these tissues from both normal and dystrophic mice. 5. It is suggested that are number of features of mouse muscular dystrophy related to altered membrane structure and function can be rationalized in terms of changes in lipid composition and metabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728103      PMCID: PMC1186199          DOI: 10.1042/bj1760015

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Tissue lipids of dystrophia muscularis, a mouse with inherited muscular dystrophy.

Authors:  R L SHULL; R B ALFIN-SLATER
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

2.  The function of cytidine coenzymes in the biosynthesis of phospholipides.

Authors:  E P KENNEDY; S B WEISS
Journal:  J Biol Chem       Date:  1956-09       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy.

Authors:  D A Butterfield; A D Roses; M L Cooper; S H Appel; D B Chesnut
Journal:  Biochemistry       Date:  1974-12-03       Impact factor: 3.162

5.  Axoplasmic flow of protein in the sciatic nerve of normal and dystrophic mice.

Authors:  Y Komiya; L Austin
Journal:  Exp Neurol       Date:  1974-04       Impact factor: 5.330

6.  Axoplasmic flow of phospholipids and cholesterol in the sciatic nerve of normal and dystrophic mice.

Authors:  B Y Tang; Y Komiya; L Austin
Journal:  Exp Neurol       Date:  1974-04       Impact factor: 5.330

7.  Muscle membrane protein kinase in myotonic muscular dystrophy.

Authors:  A D Roses; S H Appel
Journal:  Nature       Date:  1974-07-19       Impact factor: 49.962

8.  Studies on the acylation of lysolecithin by rat brain.

Authors:  G R Webster; R J Alpern
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

9.  Erythrocyte phospholipids in Duchenne muscular dystrophy.

Authors:  A Kalofoutis; G Jullien; V Spanos
Journal:  Clin Chim Acta       Date:  1977-01-03       Impact factor: 3.786

10.  Erythrocyte deformation in human muscular dystrophy.

Authors:  D W Matheson; J L Howland
Journal:  Science       Date:  1974-04-12       Impact factor: 47.728

View more
  4 in total

1.  Distribution and partial purification of a liver membrane protein capable of inactivating cytosol enzymes.

Authors:  G L Francis; F J Ballard
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

2.  Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging.

Authors:  Nora Tahallah; Alain Brunelle; Sabine De La Porte; Olivier Laprévote
Journal:  J Lipid Res       Date:  2007-11-17       Impact factor: 5.922

3.  Inhibition of the expression of pathology in dystrophic mouse leg muscles by immobilization.

Authors:  H Loermans; P Wirtz
Journal:  Br J Exp Pathol       Date:  1983-04

4.  Muscle metabolic remodelling patterns in Duchenne muscular dystrophy revealed by ultra-high-resolution mass spectrometry imaging.

Authors:  Ivana Dabaj; Justine Ferey; Florent Marguet; Vianney Gilard; Carole Basset; Youssef Bahri; Anne-Claire Brehin; Catherine Vanhulle; France Leturcq; Stéphane Marret; Annie Laquerrière; Isabelle Schmitz-Afonso; Carlos Afonso; Soumeya Bekri; Abdellah Tebani
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.